Home » US FDA Issues Final Rule, Extends Deadline for ODS Inhaler Ban
US FDA Issues Final Rule, Extends Deadline for ODS Inhaler Ban
May 18, 2010
The U.S. Food and Drug Administration (FDA) has issued a final rule phasing out inhalers containing ozone-depleting substances (ODS), such as chlorofluorocarbons, but has extended the deadline for certain products.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor